Structure of the LDL Receptor Extracellular Domain at Endosomal pH
Open accessAbstract
The low-density lipoprotein receptor mediates cholesterol homeostasis through endocytosis of lipoproteins. It discharges its ligand in the endosome at pH < 6. In the crystal structure at pH = 5.3, the ligand-binding domain (modules R2 to R7) folds back as an arc over the epidermal growth factor precursor homology domain (the modules A, B, β propeller, and C). The modules R4 and R5, which are critical for lipoprotein binding, associate with the β propeller via their calcium-binding loop. We propose a mechanism for lipoprotein release in the endosome whereby the β propeller functions as an alternate substrate for the ligand-binding domain, binding in a calcium-dependent way and promoting lipoprotein release.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LRAD3 lacks the EGF and β-propeller domains found in extracellular portions of LDL receptor family members.
“LRAD3 also lacks the EGF and β-propeller domains that are found in the extracellular portions of LDL receptor family members which are important for pH-induced uncoupling of ligands within acidic endosomal compartments (Davis et al., 1987; Mikhailenko et al., 1999; Rudenko et al., 2002).”
From LRAD3, A Novel Low-Density Lipoprotein Receptor Family Member That Modulates Amyloid Precursor Protein Trafficking (2011) · cites this paper as Rudenko et al., 2002
The Extracellular Domain at Endosomal pH section describes EGF-like repeats and a β-propeller in LDL-R and says the EGF precursor homology domain is required for ligand release. The Monomer description links that domain to release at acidic pH. Neither passage establishes that LRAD3 lacks these domains, so the LRAD3-specific part of the claim is unsupported by this source. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703 · see citing works
Self-citationMcNamara, J. R., Small, D. M., Li, Z., & Schaefer, E. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37557-x · Cited by 147 · see citing works
Flagged first, then by citations
Research works printed but not linked: 46
- M. S. Brown, J. L. Goldstein, Science 232, 34 (1986).
- J. L. Goldstein, H. H. Hobbs, M. S. Brown, in The Metabolic & Molecular Bases of Inherited Disease, C. R. Scriver et al., Eds. (McGraw-Hill, New York, 2001), vol. II, chap. 120, pp. 2863-2913.
- T. Yamamoto et al., Cell 39, 27 (1984).
- H. Jeon et al., Nature Struct. Biol. 8, 499 (2001).
- J. P. Segrest, M. K. Jones, H. De Loof, N. Dashti, J. Lipid Res. 42, 1346 (2001).
- D. W. Russell, M. S. Brown, J. L. Goldstein, J. Biol. Chem. 264, 21682 (1989).
- D. A. Chappell, G. L. Fry, M. A. Waknitz, L. E. Muhonen, M. W. Fladet, J. Biol. Chem. 268, 25487 (1993).
- A. D. Cooper, J. Lipid Res. 38, 2173 (1997).
- M. S. Brown, T. F. Deuel, S. K. Basu, J. L. Goldstein, J. Supramol. Struct. 8, 223 (1978).
- T. L. Innerarity, K. H. Weisgraber, S. C. Rall Jr., R. W. Mahley, Acta. Med. Scand. Suppl. 715, 51 (1987).
- D. Fass, S. Blacklow, P. S. Kim, J. M. Berger, Nature 388, 691 (1997).
- D. Clayton, I. M. Brereton, P. A. Kroon, R. Smith, FEBS Lett. 479, 118 (2000).
- W. J. Schneider, S. K. Basu, M. J. McPhaul, J. L. Gold- stein, M. S. Brown, Proc. Natl. Acad. Sci. U.S.A. 76, 5577 (1979).
- T. Simmons, Y. M. Newhouse, K. S. Arnold, T. L. Innerarity, K. H. Weisgraber, J. Biol. Chem. 272, 25531 (1997).
- C. G. Davis et al., Nature 326, 760 (1987).
- I. Mikhailenko et al., J. Cell. Sci. 112, 3269 (1999).
- Y. Miyake, S. Tajima, T. Funahashi, A. Yamamoto, J. Biol. Chem. 264, 16584 (1989).
- N. L. Daly, M. J. Scanlon, J. T. Djordjevic, P. A. Kroon, R. Smith, Proc. Natl. Acad. Sci. U.S.A. 92, 6334 (1995).
- T. L. Djordjevic, P. A. Kroon, R. Smith, Bio- chemistry 34, 14474 (1995).
- S. Bieri et al., Biochemistry 37, 10994 (1998).
- N. Beglova, C. L. North, S. C. Blacklow, Biochemistry 40, 2808 (2001).
- C. L. North, S. C. Blacklow, Biochemistry 39, 2564 (1999).
- Biochemistry 38, 3926 (1999).
- S. Saha et al., Structure 9, 451 (2001).
- N. D. Kurniawan, K. Aliabadizadeh, I. M. Brereton, P. A. Kroon, R. Smith, J. Mol. Biol. 311, 341 (2001).
- H. Jeon, G. G. Shipley, J. Biol. Chem. 275, 30458 (2000).
- D. R. Van der Westhuyzen et al., Biochem. J. 277, 677 (1991).
- T. Clackson, J. A. Wells, Science 267, 383 (1995).
- T. Doi et al., J. Biol. Chem. 269, 25598 (1994).
- S. Wragg, K. Drickamer, J. Biol. Chem. 274, 35400 (1999).
- S. G. Young, Circulation 82, 1574 (1990).
- X. Wang, R. Pease, J. Bertinato, R. W. Milne, Arterio- scler. Thromb. Vasc. Biol. 20, 1301 (2000).
- V. Raussens, C. M. Slupsky, R. O. Ryan, B. D. Sykes, J. Biol. Chem. 277, 29172 (2002).
- J. E. Chatterton et al., J. Lipid Res. 36, 2027 (1995).
- S. Keidar, A. C. Goldberg, K. Cook, J. Bateman, G. Schonfeld, J. Lipid Res. 30, 1131 (1989).
- J. R. McNamara, D. M. Small, Z. Li, E. J. Schaefer, J. Lipid Res. 37, 1924 (1996).
- Y. Toyota, T. Yamamura, Y. Miyake, A. Yamamoto, Atherosclerosis 147, 77 (1999).
- Collaborative Computational Project Number 4, Acta Crystallogr. D 50, 760 (1994).
- Z. Otwinowski, W. Minor, Methods Enzymol. 276, 307 (1997).
- E. de la Fortelle, G. Bricogne, Methods Enzymol. 276, 472 (1997).
- A.T. Brunger et al., Acta Crystallogr. D 54, 905 (1988).
- J.-C. P. Gabriel, R. Nagarajan, S. Natarajan, A. K. Cheetham, C. N. R. Rao, J. Solid State Chem. 129, 257 (1997).
- J. D. Thompson, D. G. Higgins, T. J. Gibson, Nucleic Acids Res. 22, 4673 (1994).
- P. J. Kraulis, J. Appl. Crystallogr. 24, 946 (1991).
- E. A. Merritt, D. J. Bacon, Methods Enzymol. 277, 505 (1997).
- A. Nicholls, K. Sharp, B. Honig, Proteins 11, 281 (1991).
Cited by
Sorted by citations
Mechanisms and regulation of cholesterol homeostasis
Luo, J., Yang, H., & Song, B.-L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0190-7 · Cited by 1,980 · see citing works
LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:Arrows point the way
He, X., Semenov, M., Tamai, K., & Zeng, X. (2004) · Development · doi:10.1242/dev.01117 · Cited by 1,044 · see citing works
Identification of the receptor scavenging hemopexin-heme complexes
Hvidberg, V., Maniecki, M. B., Jacobsen, C., Højrup, P., Møller, H. J., & Moestrup, S. K. (2005) · Blood · doi:10.1182/blood-2005-03-1185 · Cited by 473 · see citing works
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Feringa, F. M., & van der Kant, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690372 · Cited by 226 · see citing works
NetCGlyc 1.0: Prediction of mammalian C-mannosylation sites
Julenius, K. (2007) · Glycobiology · doi:10.1093/glycob/cwm050 · Cited by 174 · see citing works
Two phases of disulfide bond formation have differing requirements for oxygen
Koritzinsky, M., Levitin, F., van den Beucken, T., Rumantir, R. A., Harding, N. J., Chu, K. C., Boutros, P. C., Braakman, I., & Wouters, B. G. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201307185 · Cited by 136 · see citing works
Regulation of PCSK9 by nutraceuticals
Momtazi, A. A., Banach, M., Pirro, M., Katsiki, N., & Sahebkar, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.023 · Cited by 131 · see citing works
PCSK9 acts as a key regulator of Aβ clearance across the blood–brain barrier
Mazura, A. D., Ohler, A., Storck, S. E., Kurtyka, M., Scharfenberg, F., Weggen, S., Becker-Pauly, C., & Pietrzik, C. U. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04237-x · Cited by 53 · see citing works
Ranganathan, S., Noyes, N. C., Migliorini, M., Winkles, J. A., Battey, F. D., Hyman, B. T., Smith, E., Yepes, M., Mikhailenko, I., & Strickland, D. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5065-10.2011 · Cited by 49 · see citing works
“LRAD3 also lacks the EGF and -propeller domains that are found in the extracellular portions of LDL receptor family members that are important for pH-induced uncoupling of ligands within acidic endosomal compartments (Davis et al., 1987; Mikhailenko et al., 1999; Rudenko et al., 2002).”
BackgroundMazura, A. D., & Pietrzik, C. U. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041268 · Cited by 9 · see citing works
- Authors
- Rudenko, G., Henry, L., Henderson, K., Ichtchenko, K., Brown, M. S., Goldstein, J. L., & Deisenhofer, J.
- Affiliations
- Department of Biochemistry,
- Howard Hughes Medical Institute (US)
- Lawrence Berkeley National Laboratory (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Ichtchenko, Konstantin
- Deisenhofer, Johann
- Venue
- Science
- Published
- 2002-12-20
- Volume
- 298
- Issue
- 5602
- Pages
- 2353-2358
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1576019382
- Cited by
- 482
- References
- 2
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 14 · 2023: 22 · 2022: 16 · 2021: 22 · 2020: 17 · 2019: 25 · 2018: 16 · 2017: 15 · 2016: 21 · 2015: 15 · 2014: 24 · 2013: 20 · 2012: 14
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- green
- escholarship.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- University of North Texas Digital Library (University of North Texas) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Lawrence Berkeley National Laboratory
- Funders
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- LDL receptor, extracellular domain, endosomal pH, ligand dissociation, beta-propeller, calcium-binding loop, lipoprotein binding, cholesterol homeostasis, endocytosis, crystal structure
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Calcium, Crystallization, Epidermal Growth Factor, Humans, Hydrogen-Ion Concentration, Ligands, Lipoproteins, LDL, Models, Biological, Models, Molecular, Mutation, Protein Binding, Protein Conformation, Protein Precursors, Receptors, LDL, Endosomes, Protein Structure, Secondary, Protein Structure, Tertiary, Protein Folding, Crystallography, X-Ray, Repetitive Sequences, Amino Acid, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review